Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Dilmurodjon Eshmuminov is active.

Publication


Featured researches published by Dilmurodjon Eshmuminov.


British Journal of Surgery | 2016

Meta‐analysis of associating liver partition with portal vein ligation and portal vein occlusion for two‐stage hepatectomy

Dilmurodjon Eshmuminov; Dimitri Aristotle Raptis; Michael Linecker; Andrea Wirsching; Mickael Lesurtel; P.-A. Clavien

Discussion is ongoing regarding whether associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) or portal vein occlusion is better in staged hepatectomy. The aim of this study was to compare available strategies using a two‐stage approach in extended hepatectomy.


Informatics for Health & Social Care | 2014

Managing multicentre clinical trials with open source

Dimitri Aristotle Raptis; Tobias Mettler; Michael A. Fischer; Michael A. Patak; Mickael Lesurtel; Dilmurodjon Eshmuminov; Olivier de Rougemont; Rolf Graf; Pierre-Alain Clavien; Stefan Breitenstein

Background: Multicentre clinical trials are challenged by high administrative burden, data management pitfalls and costs. This leads to a reduced enthusiasm and commitment of the physicians involved and thus to a reluctance in conducting multicentre clinical trials. Objective: The purpose of this study was to develop a web-based open source platform to support a multi-centre clinical trial. Methods: We developed on Drupal, an open source software distributed under the terms of the General Public License, a web-based, multi-centre clinical trial management system with the design science research approach. Results: This system was evaluated by user-testing and well supported several completed and on-going clinical trials and is available for free download. Conclusion: Open source clinical trial management systems are capable in supporting multi-centre clinical trials by enhancing efficiency, quality of data management and collaboration.


Transplant International | 2018

Perfusion settings and additives in liver normothermic machine perfusion with red blood cells as oxygen carrier. A systematic review of human and porcine perfusion protocols

Dilmurodjon Eshmuminov; Filippo Leoni; Marcel André Schneider; Dustin Becker; Xavier Muller; Christopher H. Onder; Max Hefti; Martin J. Schuler; Philipp Dutkowski; Rolf Graf; Philipp Rudolf von Rohr; Pierre-Alain Clavien; Lucia Bautista Borrego

Liver machine perfusion (MP) at normothermic temperature (NMP) is a promising way to preserve and evaluate extended criteria donor livers. Currently, no consensus exists in methodology and perfusion protocols. Here, the authors performed a systematic literature search to identify human and porcine studies reporting on liver NMP with red blood cells. A qualitative synthesis was performed concerning technical aspects of MP, fluid composition, gas supply, and liver positioning. Thirty‐seven publications including 11 human and 26 porcine studies were considered for qualitative synthesis. Control mode, pressure, flow, perfusate additives, and targeted blood gas parameters varied across human as well as porcine studies. For future analyses, it is advisable to report flow adjusted to liver weight and exact pressure parameters including mean, systolic, and diastolic pressure. Parenteral nutrition and insulin addition was common. Parenteral nutrition included amino acids and/or glucose without lipids. Taurocholic acid derivatives were used as bile flow promoters. However, short‐term human NMP without taurocholic acid derivatives seems to be possible. This finding is relevant due to the lack of clinical grade bile salts. Near physiological oxygen tension in the perfusate is doable by adjusting gas flows, while blood gas parameters regulation needs more detailed description.


Transplant International | 2014

Novel rescue procedure for inferior vena cava reconstruction in living-donor liver transplantation using a vascular graft recovered 25 h after donors' circulatory death and systematic review

Adrian Fernando Palma; Christian E. Oberkofler; Dimitri Aristotle Raptis; Dilmurodjon Eshmuminov; Olivier de Rougemont; Aurelia Schnyder; Dimitrios Dimitroulis; Mickael Lesurtel; Philipp Dutkowski; Pierre-Alain Clavien

Liver transplantation is a lifesaving treatment for patients suffering from end‐stage liver disease. Rarely, acute congestion of the inferior vena cava (IVC) is being encountered because of tumor compression. MELD allocation does not reflect severity of this condition because of lack of organ failure. Herein, a patient is being presented undergoing urgent living‐donor liver transplantation (LDLT) with IVC reconstruction for a fast‐growing hepatic epithelioid hemangioendothelioma (HEH). IVC reconstruction using a venous graft recovered from a 25‐h after circulatory‐death prior transplantation became necessary to compensate severe venous congestion. Additionally, a systematic review of the literature searching MEDLINE/PubMed was performed. Protocol and eligibility criteria were specified in advance and registered at the PROSPERO registry (CRD42013004827). Published literature of IVC reconstruction in LDLT was selected. Two reports describing IVC reconstruction with cryopreserved IVC grafts and one IVC reconstruction using a deceased after‐circulatory‐death‐donor IVC graft were included. Follow‐up was at 12 and 13 months, respectively. Regarding the graft recovery in the setting of living‐related donation, this graft remained patent during the nine‐month follow‐up period. This is the first report on the use of a venous graft from a circulatory‐death‐donor, not eligible for whole organ recovery. We demonstrate in this study the feasibility of using a size and blood‐group‐compatible IVC graft from a cold‐stored donor, which can solve the problem of urgent IVC reconstruction in patients undergoing LDLT.


Transplant International | 2018

Reply to “Ex situ normothermic machine perfusion of donor livers using a haemoglobin-based oxygen carrier: a viable alternative to red blood cells”

Dilmurodjon Eshmuminov; Filippo Leoni; Marcel André Schneider; Dustin Becker; Xavier Muller; Max Hefti; Martin J. Schuler; Christopher H. Onder; Philipp Dutkowski; Rolf Graf; Philipp Rudolf von Rohr; Pierre-Alain Clavien; Lucia Bautista Borrego

We highly appreciate the interest expressed in the letter by de Vries et all concerning our recent systematic review (1, 2), and congratulate for the successful transplantation using HBOC during normothermic perfusion. We agree, that ex situ normothermic and also subnormothermic liver perfusion using HBOC is per se an interesting option to spare red blood cells as oxygen carrier. This article is protected by copyright. All rights reserved.


World Journal of Surgery | 2016

Where Oncologic and Surgical Complication Scoring Systems Collide: Time for a New Consensus for CRS/HIPEC

Kuno Lehmann; Dilmurodjon Eshmuminov; Ksenija Slankamenac; Benedict Kranzbühler; Pierre-Alain Clavien; René Vonlanthen; Philippe Gertsch


Annals of Surgical Oncology | 2017

Major Postoperative Complications Are a Risk Factor for Impaired Survival after CRS/HIPEC

Marcel André Schneider; Dilmurodjon Eshmuminov; Kuno Lehmann


Surgery | 2017

Rapid liver volume increase induced by associating liver partition with portal vein ligation for staged hepatectomy (ALPPS): Is it edema, steatosis, or true proliferation?

Dilmurodjon Eshmuminov; Christoph Tschuor; Dimitri Aristotle Raptis; Andreas Boss; Moritz C. Wurnig; Gregory Sergeant; Erik Schadde; Pierre-Alain Clavien


Ejso | 2017

18FDG-PET-CT improves specificity of preoperative lymph-node staging in patients with intestinal but not diffuse-type esophagogastric adenocarcinoma

Kuno Lehmann; Dilmurodjon Eshmuminov; Peter Bauerfeind; C. Gubler; Patrick Veit-Haibach; Achim Weber; H. Abdul-Rahman; Michael A. Fischer; C. Reiner; P.M. Schneider


Hpb | 2016

Liver kinetic growth rate predicts postoperative liver failure after ALPPS

Patryk Kambakamba; Daniel Stocker; Cäcilia S. Reiner; Thi Dan Linh Nguyen-Kim; Michael Linecker; Dilmurodjon Eshmuminov; Henrik Petrowsky; Pierre-Alain Clavien; Mickael Lesurtel

Collaboration


Dive into the Dilmurodjon Eshmuminov's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge